Koji Nakamura

Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan.

Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Factory Ltd. is a pharmaceutical company based in Osaka, Japan. The Japanese company produces integrated production from raw drugs to pharmaceuticals, designed preparation, and clinical trial drug manufacturing. The company supports diverse human resources through the enhancement of the compatible support system between life events and work, the introduction of a flexible working system, and work on work style reform and diversity initiatives. The company also promotes environmental safety management and management that is friendly to the earth.